Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 2008 Jan; 58(1):106-15.
View in:
PubMed
subject areas
Adalimumab
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Double-Blind Method
Female
Humans
Male
Middle Aged
Psoriasis
Severity of Illness Index
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
Kenneth Gordon